New study solves an arthritis drug mystery
MIT biological engineers discover why a promising drug failed in clinical trials.
MIT biological engineers discover why a promising drug failed in clinical trials.
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Mechanical engineering researchers are developing new and innovative ways to improve health care.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
Collaboration with pharmaceutical giant will bring smart jet-injection device to market.
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
Studies by Richard Wurtman have led to development of nutrient mix shown to slow cognitive impairment in early stages of the disease.
Youth-to-youth program teaches girls about the increased odds of contracting HIV from older men.
The 2017 Transcatheter Cardiovascular Therapeutics Career Achievement Award honors a pioneering biomedical engineer, scientist, professor, and cardiologist.
Ingestible devices could diagnose gastrointestinal slowdown or monitor food intake.
Cutting off a process that cancerous cells rely on can force them to stop growing.
Paper-based diagnostic avoids false positives from Dengue fever and other related viruses.
Assistant professors Joey Davis and Rebecca Lamason will spearhead research initiatives into fundamental cellular processes.
Study finds bacterial response to drugs varies in different environments.